Approximately 1.5 million Preview Strep A Test Kits, including brands like Clarity, Areta, and IMCO, are being recalled because they were distributed for at-home and over-the-counter use without proper authorization. These rapid test kits are intended for professional medical use only, and about 1,586,255 units have been affected across several brand names. Using these professional-grade tests at home may lead to incorrect results or improper treatment decisions.
Because these tests were not approved for consumer use at home, there is a risk of users misinterpreting results or performing the test incorrectly. This could lead to a false negative or false positive result, delaying necessary medical treatment for a Strep A infection or leading to unnecessary antibiotic use.
Professional use device improperly sold to consumers.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.